News | Mammography | October 21, 2019

Breast cancer diagnostic center to give women in the United States same-day results on mammograms

GE Healthcare and Premier Inc. Developing One-stop Breast Clinic Model for U.S.

October 21, 2019 — GE Healthcare and Premier Inc. have announced a collaboration to develop a model to bring a same-day breast cancer diagnosis and treatment model to the United States. A similar model has already proven effective at the Gustave Roussy Cancer Campus in France.

Launched in 2004, the One-Stop Clinic at the Gustave Roussy Institute in France offers a coordinated patient journey from the initial appointment through diagnosis and treatment plan in one place, on one day and with one team. With a multimodality approach that includes the GE Healthcare Senographe Pristina mammography system, SenoBright contrast enhanced spectral mammography (CESM) and biopsy, the program has proven to be successful, with an 80 percent patient satisfaction rating.

“We’ve seen the benefit of taking a personalized approach to breast care that includes different modalities and a multidisciplinary team to ensure we get answers to our patients as quickly as possible,” said Joseph Russo, M.D., section chief of women's imaging at St. Luke's University Health Network, and a member of the Advisory Board with GE Healthcare and Premier. “The One-Stop Clinic takes this a step further to offer proven same-day results that are incredibly impactful for patients and clinicians. I couldn’t be more excited to work with GE Healthcare and Premier to bring similar outcomes to life in the United States.”

To support the effort, Premier conducted a Rapid Evidence Review, one of the first comprehensive evaluations of expedited diagnosis for patients with breast cancer. Based on the results of the first phase of the collaboration, GE Healthcare and Premier will next evaluate the potential and merits associated with adopting the One-Stop Clinic model in the United States. The companies have convened an advisory board to provide insight on the One-Stop Clinic model, as well as guidance and counsel on best approaches to redesign it for the U.S. market.

To date, more than 20,000 women have participated in this program, and 75 percent of women leave with their diagnosis on the same day. The idea and design of the clinic were pioneered by Suzette Delaloge, M.D., an oncologist and head of the Breast Cancer Department at Gustave Roussy.

Read the article “Practicing Patient-centered Mammography”

For more information: www.gehealthcare.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
Subscribe Now